Overview
Varsha Sharda is a Hematologist and an Oncologist in Rochester, New York. Dr. Sharda has been practicing medicine for over 43 years and is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
601 Elmwood Ave, Rochester, NY 14642
University Of Rochester
Aram Hezel is a Hematologist Oncology specialist and an Oncologist in Rochester, New York. Dr. Hezel is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.
University Of Rochester
Daniel Mulkerin is an Oncologist and a Palliative Medicine provider in Rochester, New York. Dr. Mulkerin is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Neuroendocrine Tumor, and Familial Pancreatic Cancer.
University Of Rochester
Hugo Valencia is a Hematologist Oncology specialist and an Oncologist in Rochester, New York. Dr. Valencia is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Waldenstrom Macroglobulinemia, Neuroendocrine Tumor, and Small Cell Lung Cancer (SCLC).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Sharda isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Lung AdenocarcinomaDr. Sharda isDistinguished. Learn about Lung Adenocarcinoma.
- Small Cell Lung Cancer (SCLC)Dr. Sharda isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Sharda isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- AngiosarcomaDr. Sharda isAdvanced. Learn about Angiosarcoma.
- EGFR Positive Lung CancerDr. Sharda isAdvanced. Learn about EGFR Positive Lung Cancer.
- Inflammatory Breast CancerDr. Sharda isAdvanced. Learn about Inflammatory Breast Cancer.
- Large-Cell Lung CarcinomaDr. Sharda isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Non-Small Cell Lung Cancer (NSCLC)
- Paget Disease of the BreastDr. Sharda isAdvanced. Learn about Paget Disease of the Breast.
- Experienced
- Anal CancerDr. Sharda isExperienced. Learn about Anal Cancer.
- Breast CancerDr. Sharda isExperienced. Learn about Breast Cancer.
- Colorectal CancerDr. Sharda isExperienced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Sharda isExperienced. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Sharda isExperienced. Learn about Familial Pancreatic Cancer.
- Gastroesophageal Junction CancerDr. Sharda isExperienced. Learn about Gastroesophageal Junction Cancer.